This 1-page brochure provides a brief overview of the ArteraAI Prostate Test, including key features and benefits for clincians and patients. This test is for patients who have been diagnosed with localized prostate cancer who have not yet received radiation therapy.
Related Articles
ArteraAI Achieves SOC 2 Type II Security Compliance Certification
ArteraAI x SOC 2 As part of our commitment to cybersecurity, we are proud to announce that ArteraAI is now SOC 2 Type II cert [...]
ArteraAI Predictive Models
ArteraAI is a leading precision medicine company developing AI tests to personalize cancer therapy. Download the pdf.